Speaker Details

Brian S Kim, MD, FAAD

Brian S Kim, MD, FAAD

SESSIONS

S003 Chronic Pruritus: Bedside to Bench Perspectives
Mar 8, 2024 • 9:00 AM - 12:00 AM • Room 6C
F050 Itch
Mar 9, 2024 • 9:00 AM - 12:00 AM • Room 6D
P151 Plenary
Mar 10, 2024 • 8:45 AM - 12:00 AM • Room 20B

DISCLOSURES

AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Alys Pharmaceuticals – Stockholder Private Company(Stock); AstraZeneca – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Consultant(Fees); Septerna – Consultant (1099 relationship)(Fees);